Dr. Husain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
243 Charles St
12th Floor
Boston, MA 02114
Education & Training
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1998 - 2001
- Jawaharlal Nehru Medical CollegeClass of 1986
Certifications & Licensure
- MA State Medical License 2001 - 2025
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD Start of enrollment: 2021 Feb 04
Roles: Contact
Publications & Presentations
PubMed
- Association of plasma metabolites with treatment response after intravitreal anti-vascular endothelial growth factor injections in treatment-naïve neovascular age-rela...Hae Min Kang, Kevin M Mendez, Inês Laíns, Krupa Sourirajan, Roshni Bhat
BMJ Open Ophthalmology. 2025-03-15 - Functional genomics in age-related macular degeneration: From genetic associations to understanding disease mechanisms.Rinki Ratnapriya, Felix Grassman, Rui Chen, Alex Hewitt, Jianhai Du
Experimental Eye Research. 2025-03-13 - ASSESSING THE REPEATABILITY OF INNER CHOROID FLOW DEFICIT PERCENTAGE IN INTERMEDIATE AGE-RELATED MACULAR DEGENERATION AND CONTROLS: A Comparative Study Between Differe...Francesco Romano, Xinyi Ding, Mauricio Garcia, Yan Zhao, Filippos Vingopoulos
Retina. 2025-03-01
Journal Articles
- Metabolomics in the Study of Retinal Health and DiseaseDeeba Husain, Martin Friedlander, ScienceDirect
Press Mentions
- Metabolomics May Enable Early Diagnosis, Treatment in Macular DegenerationAugust 18th, 2020
- AMD Biomarkers Identified by MetabolomicsNovember 1st, 2018
- Researchers Identify Potential Biomarkers of Age-Related Macular DegenerationSeptember 14th, 2017
Grant Support
- Metabolomics a Novel Tool for Investigating the Pathogenesis of Age-related Macular DegenerationMASSACHUSETTS EYE AND EAR INFIRMARY2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: